Generalized Periodic Discharges After Convulsive Status Epilepticus
A 64-year-old woman with no prior epilepsy is brought in after 25 minutes of witnessed generalized tonic-clonic activity. She received lorazepam 2 mg IV twice (4 mg total) and levetiracetam 4.5 g IV over 15 minutes. Convulsions stopped, but 40 minutes later she remains unresponsive with no eye opening. MAP 62 mmHg on norepinephrine 8 mcg/min, HR 96, SpO2 96% on 6 L. Creatinine 2.1 mg/dL, ALT 210 U/L, platelets 78,000, ammonia normal, CK 1,200 U/L. She is on propofol 60 mcg/kg/min for ongoing unresponsiveness. Continuous EEG shows 2 Hz generalized periodic discharges, some with a plus modifier, and intermittent rhythmic delta. The EEG technologist notes subtle left eyelid twitching.
1. Does this EEG represent nonconvulsive status epilepticus or an ictal-interictal pattern? How do you decide, and does the distinction change what you do tonight?
Read the worked answer
Treat this as nonconvulsive status epilepticus.
Applying the Salzburg criteria:
- Definite NCSE requires epileptiform discharges >2.5 Hz, or ≤2.5 Hz with either clinical or electrographic improvement after a benzodiazepine challenge.
- Possible NCSE is ≤2.5 Hz discharges with fluctuation, spatial evolution, or a plus modifier, or subtle clinical ictal phenomena.
- She scores on the 'possible' tier twice over: 2 Hz generalized periodic discharges with a plus modifier, AND a subtle clinical correlate (left eyelid twitching at the bedside). Subtle twitching alongside GPDs is ictal until proven otherwise.
- Context matters. She just had 25 minutes of convulsive activity and remains unresponsive well beyond what the lorazepam should produce - the post-ictal explanation cannot carry this.
Why the distinction matters tonight: an ictal-interictal continuum pattern in an awake, recovering patient can be observed; in a persistently comatose patient with a plus modifier and a motor correlate it should be treated. Practically: give a benzodiazepine challenge under EEG observation with airway support ready, and if the pattern or the twitching resolves, escalate to a continuous anesthetic agent. Do not spend the night debating nomenclature while she is in status.
2. She is already on propofol, MAP is 62 mmHg, and she has renal and hepatic dysfunction with thrombocytopenia. What is your escalation strategy, and which agents do you avoid?
Read the worked answer
Escalate to a continuous anesthetic with a second mechanism, but first fix the perfusion pressure.
- Fix MAP first. MAP 62 mmHg in an actively seizing brain is inadequate; seizures and hyperthermia increase metabolic demand while hypotension limits delivery. Titrate norepinephrine to MAP ≥80, place an arterial line, and use the lowest effective anesthetic dose.
- Propofol is a reasonable backbone but at this dose it is already approaching the range where propofol-related infusion syndrome becomes a concern - watch for rising CK (already 1,200), lactic acidosis, triglycerides, arrhythmia, and rhabdomyolysis. Duration >48 h at high dose is the main risk.
- Midazolam is the usual second agent. Its active metabolite accumulates in renal failure and produces prolonged sedation that confounds later examinations; accept that and plan for a longer washout, or choose an alternative.
- Avoid valproate - platelets 78,000 and ALT 210 make hepatotoxicity and further thrombocytopenia likely.
- Consider ketamine as a hemodynamically favorable third-line anesthetic adjunctive; it supports pressure and does not accumulate in renal failure.
- Add an enteral agent (lacosamide, topiramate, or phenobarbital) as a bridge so the anesthetic can be weaned, and monitor lacosamide with cardiac conduction in mind.
3. She is seizure-free on continuous EEG. How deep do you titrate, how long do you maintain it, and what is your weaning plan?
Read the worked answer
Target electrographic suppression, not a fixed number of days.
- Depth. For generalized convulsive SE that has become refractory, the standard goal is burst suppression (or at least complete suppression of discrete ictal discharges) for 24-48 hours after the last electrographic seizure. Titrate to effect on EEG, not to a drug dose; if a deeper endpoint worsens blood pressure, accept cessation of ictal activity with an acceptable suppression pattern.
- Duration. 24-48 h of control is generally sufficient for a first episode. Prolonging deep suppression beyond that buys nothing and adds propofol-infusion, ileus, and infection risk. Extended suppression is reserved for recurring seizures on weaning.
- Weaning. Taper over 24-48 h with continuous EEG running, reducing by a defined step every few hours; supervise with an epileptologist. Have a plan for recurrent seizures (re-bolus, restart at the last effective rate).
- Look for the cause during the wean. MRI with DWI in the next 72 h, CSF analysis if there is fever or immunosuppression, and autoimmune/paraneoplastic serology in new-onset cryptogenic status - the 64-year-old with new-onset SE deserves this workup.
- Do not forget the confounder. Renal failure, hepatic dysfunction, and prolonged sedation mean the neurologic exam will lag the EEG; plan extubation and prognostication around that, not around day 2.